Edmond de Rothschild Holding’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276K Sell
784
-22
-3% -$7.84K ﹤0.01% 360
2025
Q4
$264K Hold
806
﹤0.01% 367
2025
Q3
$227K Sell
806
-330
-29% -$95.7K ﹤0.01% 379
2025
Q2
$317K Sell
1,136
-576
-34% -$163K 0.01% 359
2025
Q1
$533K Hold
1,712
0.01% 315
2024
Q4
$446K Sell
1,712
-516
-23% -$153K 0.01% 343
2024
Q3
$718K Buy
2,228
+309
+16% +$101K 0.01% 298
2024
Q2
$600K Sell
1,919
-311
-14% -$91.4K 0.01% 325
2024
Q1
$634K Buy
2,230
+866
+63% +$253K 0.01% 341
2023
Q4
$393K Sell
1,364
-10,631
-89% -$2.9M 0.01% 377
2023
Q3
$3.22M Sell
11,995
-61,754
-84% -$15.4M 0.07% 190
2023
Q2
$16.4M Sell
73,749
-3,532
-5% -$820K 0.32% 82
2023
Q1
$18.7M Sell
77,281
-35,756
-32% -$8.78M 0.43% 64
2022
Q4
$29.7M Sell
113,037
-9,338
-8% -$2.5M 0.69% 46
2022
Q3
$27.6M Sell
122,375
-3,296
-3% -$799K 0.73% 37
2022
Q2
$30.6M Sell
125,671
-47,854
-28% -$11.7M 0.74% 38
2022
Q1
$42M Buy
173,525
+6,155
+4% +$1.41M 0.91% 29
2021
Q4
$37.7M Sell
167,370
-10,075
-6% -$2.13M 0.81% 34
2021
Q3
$37.7M Sell
177,445
-1,550
-0.9% -$357K 0.87% 30
2021
Q2
$43.6M Buy
178,995
+52,328
+41% +$12.9M 1.01% 21
2021
Q1
$31.5M Buy
126,667
+56,058
+79% +$13.4M 0.86% 27
2020
Q4
$16.2M Buy
70,609
+7,809
+12% +$1.8M 0.54% 53
2020
Q3
$16M Sell
62,800
-32,570
-34% -$8.07M 0.63% 47
2020
Q2
$22.5M Buy
95,370
+33,013
+53% +$7.53M 0.93% 27
2020
Q1
$12.6M Sell
62,357
-2,109
-3% -$461K 0.66% 38
2019
Q4
$15.5M Sell
64,466
-4,166
-6% -$918K 0.61% 54
2019
Q3
$13.3M Buy
68,632
+22,153
+48% +$4.25M 0.53% 53
2019
Q2
$8.57M Buy
46,479
+30,010
+182% +$5.37M 0.32% 80
2019
Q1
$3.13M Buy
16,469
+1
+0% +$191 0.11% 148
2018
Q4
$3.21M Sell
16,468
-200
-1% -$39K 0.11% 137
2018
Q3
$3.46M Sell
16,668
-136
-0.8% -$26.8K 0.1% 159
2018
Q2
$3.1M Buy
16,804
+400
+2% +$70.8K 0.09% 172
2018
Q1
$2.8M Sell
16,404
-7,920
-33% -$1.45M 0.08% 179
2017
Q4
$4.23M Sell
24,324
-2,601
-10% -$460K 0.12% 144
2017
Q3
$5.02M Buy
26,925
+303
+1% +$53.7K 0.14% 121
2017
Q2
$4.58M Sell
26,622
-91,843
-78% -$14.9M 0.13% 137
2017
Q1
$19.4M Buy
118,465
+1,553
+1% +$258K 0.52% 61
2016
Q4
$17.1M Buy
116,912
+7,392
+7% +$1.11M 0.47% 65
2016
Q3
$18.3M Buy
109,520
+12,928
+13% +$2.19M 0.55% 57
2016
Q2
$14.7M Sell
96,592
-9,700
-9% -$1.51M 0.47% 61
2016
Q1
$15.9M Hold
106,292
0.51% 57
2015
Q4
$17.3M Sell
106,292
-6,400
-6% -$1.01M 0.46% 62
2015
Q3
$15.6M Buy
112,692
+1,393
+1% +$220K 0.39% 69
2015
Q2
$17.1M Buy
+111,299
New +$17.8M 0.37% 69

Other funds holding AMGN

Edmond de Rothschild Holding's AMGN Position: Q1 2026 in Review

Edmond de Rothschild Holding reduced its Amgen (AMGN) stake by 2.7% in Q1 2026, selling an estimated $7.84K and leaving 784 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Edmond de Rothschild Holding first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $43.6M in Q2 2021. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Edmond de Rothschild Holding held 784 shares of Amgen worth $276K as of Q1 2026.
  • Edmond de Rothschild Holding sold 22 Amgen shares in Q1 2026, an estimated $7.84K.
  • Amgen made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #360 holding.
  • Edmond de Rothschild Holding first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • Edmond de Rothschild Holding's Amgen position peaked at $43.6M in Q2 2021.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.